Efficacy of adjunctive use of diacerein local delivery in the management of moderate chronic periodontitis
A double-blind randomized controlled trial
Keywords:
Periodontitis; Chronic periodontitis; Scaling and root planning; Diacerein; IL-β1Abstract
Background: Chronic periodontitis is a common public health concern characterized by progressive gingival inflammation. Objective: This study assessed the clinical and laboratory effect of diacerein as adjunctive therapy to scaling and root planing (SRP) in the therapeutic management of moderate chronic periodontitis. Methods: This double-blind randomized controlled trial was conducted on thirty patients suffering from moderate chronic periodontitis at the dental clinic in the Faculty of Dentistry (University of Mansoura, Egypt) between March-October 2018. The participants were randomly allocated into two groups of fifteen subjects each. The control and study group received SRP and diacerein was administered to the study group in the form of a gel-formula applied to the periodontal pocket for 6 weeks. The clinical periodontal parameters assessed pre- and post-treatment were plaque index (PI), gingival index (GI), probing depth, and clinical attachment level (CAL). Samples of gingival crevicular fluid (GCF) were also collected at baseline and six weeks after the initiation of the treatment for IL-1ß assessment using ELISA. Clinical parameters collected were compared between and after treatment by descriptive and inferential statistical analysis using IBM© SPSS© Statistics version 20. Results: Age and gender were not significantly different between the two groups. There was a significant decrease in the median values of clinical indices post-treatment compared to pre-treatment in the study group (test significance=23.07; p<0.001). Interestingly, there was a significant decrease in IL-β1 after treatment in both groups, with a more significant decrease in the study group compared to the control group (p=0.0001). Conclusion: Diacerein is an alternative and promising therapeutic option for the management and control of chronic periodontitis. Clinical Trial Registration: The trial has been registered at http://www.clinicaltrials.in.th with registration ID: TCTR20190930001. Funding: No funds or financial support, governmental or non-governmental, was receivedReferences
Silva, N. et al. Host response mechanisms in periodontal diseases. J Appl Oral Sci, 2015 May-Jun; 23(3):329-55. doi: 10.1590/1678-775720140259, PMid:26221929, PMCid: PMC4510669
Tonetti, M.S., Greenwell, H. and Kornman, K.S. Staging and grading of periodontitis: Framework and proposal of a new classification and case definition. J Periodontol. 2018;89(1):S159-S172. doi: 10.1002/JPER.18-0006, PMid: 29926952
López R, Baelum V. Periodontal disease classifications revisited. European Journal of Oral Sciences, 2015;123(6):385-9. doi: 10.1111/eos.12227, PMid: 26505468
Wiebe, C.B. and Putnins, E.E.. The periodontal disease classification system of the American Academy of Periodontology--an update. Journal (Canadian Dental Association), 2000;66(11):594-7.
American Academy of Periodontology Task Force Report on the Update to the 1999 Classification of Periodontal Diseases and Conditions. Journal of Periodontology. 2015;86(7):835-8. doi: 10.1902/jop.2015.157001, PMid: 26125117
Bartold, P.M., Cantley, M.D. and Haynes, DR. Mechanisms and control of pathologic bone loss in periodontitis. Periodontology 2000, 2010;53:55-69. doi: 10.1111/j.1600-0757.2010.00347.x, PMid: 20403105
Cochran, D.L. Inflammation and bone loss in periodontal disease. Journal of Periodontology, 2008;79(8 Suppl):1569-76. doi: 10.1902/jop.2008.080233, PMid: 18673012
Stashenko, P., Van, D.T., Tully, P., Kent, R., Sonis, S. and Tanner, A.C. Inflammation and genetic risk indicators for early periodontitis in adults. Journal of Periodontology, 2011;82(4):588-96. doi: 10.1902/jop.2010.100443, PMid:21054222, PMCid:PMC3299480
Pihlstrom, B.L., Michalowicz, B.S. and Johnson, N.W. Periodontal diseases. Lancet, 2005;19(9499):1809-20. doi: 10.1016/S0140-6736(05)67728-8
Hosn, K.N., Jefferson, M.M., Leding, C., Shokouh-Amiri, S. and Thomas, E.L. Inhibitors of bacterial protease enzymes for periodontal therapy. Clinical and Experimental Dental Research, 2015;1(1):18-25. doi: 10.1002/cre2.4, PMid:29744136, PMCid:PMC5839262 11)Anonymous. Treatment of Plaque-induced Gingivitis, Chronic Periodontitis, and Other Clinical Conditions. Pediatric Dentistry. 2017;39(6):445-54.
Nair, S.C. and Anoop, K.R. Intraperiodontal pocket: An ideal route for local antimicrobial drug delivery. Journal of Advanced Pharmaceutical Technology and Research, 2012;3(1):9-15. 13)Seydanur Dengizek, E., Serkan, D., Abubekir, E., Aysun Bay, K., Onder, O. and Arife, C. Evaluating clinical and laboratory effects of ozone in non-surgical periodontal treatment: a randomized controlled trial. J Appl Oral Sci, 2019 Jan 14;27:e20180108. doi: 10.1590/1678-7757-2018-0108, PMid: 30673028, PMCid: PMC6438664 14)Huang, R. Y., Lu, S. H., Su, K. W., Chen, J. K., Fang, W. H., Liao, W. N., Chen, S. Y. and Shieh, Y. S. Diacerein: a potential therapeutic drug for periodontal disease. Medical Hypotheses. 2012;79(2):165-7. doi: 10.1016/j.mehy.2012.04.024, PMid: 22583561 15)Panova, E. and Jones, G. Benefit-risk assessment of diacerein in the treatment of osteoarthritis. DrugSafety, 2015;38(3):245-52. doi: 10.1007/s40264-015-0266-z, PMid: 25652235 16)Zaki, B.M., Mahmoud, E.A. and Aly, A.A. Diacerein: A potential therapeutic drug for the management of experimental periodontitis in rats. Electronic Physician, 2015;7(5):1290-5. 17)Ahmad, N., Lonardo, E.C., Patel, K.J., Lin, S.Y., Wearley, L.L., Matheson, J.N. and Wiita, B. Novel methods of treating local and bacterial infections. US Patents 200301302251A, 2003 18)Kumar, L. and Verma, R. In vitro evaluation of topical gel prepared using natural polymer. International Journal of Drug Delivery, 2010;2:58-63. doi: 10.5138/ijdd.2010.0975.0215.02012 19)Sima, C. and Van Dyke, T.E. Therapeutic Targets for Management of Periodontitis and Diabetes. Current Pharmaceutical Design, 2016;22(15):2216-37. doi: 10.2174/1381612822666160216150338, PMid: 26881443 20)Baek, K., Ji, S. and Choi, Y. Complex Intratissue Microbiota Forms Biofilms in Periodontal Lesions. Journal of Dental Research, 2018;97(2):192-200. doi: 10.1177/0022034517732754, PMid: 28945499, PMCid: PMC6429573 21)AlJehani, Y.A. Risk factors of periodontal disease: review of the literature. International Journal ofDentistry, 2014;2014:182513. doi: 10.1155/2014/182513, PMid: 24963294, PMCid: PMC4055151 22)Wu, Y., Dong, G., Xiao, W., Xiao, E., Miao, F., Syverson, A., Missaghian, N., Vafa, R., Cabrera-Ortega, A. A., Rossa, C., Jr, and Graves, D. T. Effect of Aging on Periodontal Inflammation, Microbial Colonization, and Disease Susceptibility. Journal of Dental Research, 2016;95(4):460-6. doi: 10.1177/0022034515625962, PMid: 26762510, PMCid: PMC4802783 23)Petersen, P.E. and Ogawa, H. The global burden of periodontal disease: towards integration with chronic disease prevention and control. Periodontology 2000, 2012;60(1):15-39. doi: 10.1111/j.1600-0757.2011.00425.x, PMid: 22909104 24)Mendonça, S. A., Teixeira, F. G., Oliveira, K. M., Santos, D. B., Marques, L. M., Amorim, M. M. and Gestinari, R. Study of the association between the interleukin-1 β c.3954C>T polymorphism and periodontitis in a population sample from Bahia, Brazil. Contemporary Clinical Dentistry, 2015;6(2):176–82. doi: 10.4103/0976-237X.156040, PMid: 26097351, PMCid: PMC4456738 25)Al Qahtani, N.A., Joseph, B., Deepthi, A. and Vijayakumari, B.K. Prevalence of chronic periodontitis and its risk determinants among female patients in the Aseer Region of KSA. Journal of Taibah University Medical Sciences, 2017;12(3):241-8. doi: 10.1016/j.jtumed.2016.11.012, PMid: 31435246, PMCid: PMC6694882 26)Lertpimonchai, A., Rattanasiri, S., Arj-Ong Vallibhakara, S., Attia, J. and Thakkinstian, A. The association between oral hygiene and periodontitis: a systematic review and meta-analysis. International Dental Journal, 2017;67(6):332-43. doi: 10.1111/idj.12317, PMid: 28646499, PMCid: PMC5724709 27)Schätzle M. et al. Clinical course of chronic periodontitis. III. Patterns, variations and risks of attachment loss. Journal of Clinical Periodontology, 2003;30(10):909-18. doi: 10.1034/j.1600-051X.2003.00401.x, PMid: 14710771 28)Sanz. I., Alonso, B., Carasol, M., Herrera, D. and Sanz, M. Nonsurgical treatment of periodontitis. Journal of Evidence-Based Dental Practice, 2012;12(3 Suppl):76-86. doi: 10.1016/S1532-3382(12)70019-2 29)Allam, A.N., Hamdallah, S.I. and Abdallah, O.Y. Chitosan-coated diacerein nanosuspensions as a platform for enhancing bioavailability and lowering side effects: preparation, characterization, and ex vivo/in vivo evaluation. International Journal of Nanomedicine. 2017;12:4733–45. doi: 10.2147/IJN.S139706, PMid: 28740381, PMCid: PMC5503500 30)Gomes, F.I., Aragão, M.G., Barbosa, F.C., Bezerra, M.M., de Paulo Teixeira Pinto, V. and Chaves, H.V. Inflammatory Cytokines Interleukin-1β and Tumour Necrosis Factor-α - Novel Biomarkers for the Detection of Periodontal Diseases: a Literature Review. Journal of Oral and Maxillofacial Research, 2016;7(2):e2. doi: 10.5037/jomr.2016.7202, PMCid: PMC4970502 31)Ebersole, J.L., Nagarajan, R., Akers, D. and Miller, C.S. Targeted salivary biomarkers for discrimination of periodontal health and disease(s). Frontiers in Cellular and Infection Microbiology, 2015;5:62. doi: 10.3389/fcimb.2015.00062, PMid: 26347856, PMCid: PMC4541326 32)Deshpande, N. and Dave, D. Antigen-presenting cells in periodontal disease. Indian Journal of Oral Sciences, 2012;3(2):69-73. doi: 10.4103/0976-6944.106457 33)Miller, C.S., King, C.P. Jr., Langub, M.C., Kryscio, R.J. and Thomas, M.V. Salivary biomarkers of existing periodontal disease: a cross-sectional study. Journal of The American Dental Association, 2006;137(3):322-9. doi: 10.14219/jada.archive.2006.0181, PMid: 16570465
Downloads
Published
Issue
Section
License
Copyright (c) 2020 Knowledge Kingdom Publishing
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
